Our major investors include well-known VC funds, SV Health Investors, New Leaf Venture Partners and Novo Ventures.

In 2012, Karus secured a £25 million ($39 million) Series B investment led by SV Life Sciences (now SV Health Investors), New Leaf Ventures, Novo A/S and International Biotechnology Trust, which joined existing investors, IP Group and several Business Angels.

In October 2018, Karus secured an additional £12 million from SV Health Investors, New Leaf Venture Partners, Novo Ventures and several pre-existing individual investors and Business Angels.

In August 2020, Karus secured an additional £1.5 million as a Convertible Loan under the UK Government Future Fund programme, which included investment from SV Health Investors, New Leaf Venture Partners, Novo Ventures and some pre-existing individual investors.